Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Plos One|February 20, 2014
Outcomes in patients with acute and stable coronary syndromes; insights from the prospective NOBORI-2 studyFarzin Fath-Ordoubadi, Erik Spaepen, Magdi El-Omar, et al.
Primary Care Diabetes|December 3, 2023
Barriers and solutions for the management of severe hypoglycaemia in people with diabetes in Spain: A Delphi surveyDomingo Orozco-Beltrán, Adriana López Pineda, José Antonio Quesada, et al.
Cureus|March 20, 2025
Glucometrics and Patient-Reported Outcomes in Individuals With Type 1 Diabetes Mellitus: Insights From the Correlation of Time in Range (CorrelaTIR) Study in Real-World SettingsEsther Artime, Natalia Hillman, Francisco J Tinahones, et al.
The American Journal of Cardiology|June 4, 2015
Prevalence and Impact of Co-morbidity Burden as Defined by the Charlson Co-morbidity Index on 30-Day and 1- and 5-Year Outcomes After Coronary Stent Implantation (from the Nobori-2 Study)Mamas A Mamas, Farzin Fath-Ordoubadi, Gian B Danzi, et al.
Transfusion|July 31, 2020
Comparison of the platelet activation status of single-donor platelets obtained with two different cell separator technologiesDaniel Millar, Chelsea Hayes, Jessica Jones, et al.
Journal of Vascular and Interventional Radiology : JVIR|May 5, 2018
Chemoembolization of Hepatocellular Carcinoma with Drug-Eluting Polyethylene Glycol Embolic Agents: Single-Center Retrospective Analysis in 302 PatientsFilipe Veloso Gomes, João A Oliveira, Mariana Tomé Correia, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 25, 2019
Patient Preferences and Health State Utilities Associated with Mealtime Insulin Concentrations Among Patients with Diabetes in ItalyLouis S Matza, Beatrice Osumili, Katie D Stewart, et al.
Patient Preference and Adherence|May 7, 2025
Higher Compliance with Treatment Administration Instructions for Injectable Dulaglutide versus Oral Semaglutide Reported by People with Type 2 Diabetes in Clinical Practice Settings in Spain: The TRU-Experience StudySilvia Díaz-Cerezo, Esther Artime, Jennifer Redondo-Antón, et al.
Pageof 5